GNTA · Genenta Science SpA ADR
United States · RS rating 8 · As of 2026-10-14
| Price | 0.66 USD |
|---|---|
| 1-day change | -8.6% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 11 / 4 / 6 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 4 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +89.3% |
| Market cap (USD) | $16.6M |